Evidence map›Paper›PMID 27784306›Full record

ArticleJournal of translational medicine2016

Angiopoietin-2 impairs collateral artery growth associated with the suppression of the infiltration of macrophages in mouse hindlimb ischaemia.

Xiaoyong Tan, Kai Yan, Meiping Ren, Ni Chen, Yongjie Li, Xin Deng, Liqun Wang, Rong Li, Mao Luo, Yong Liu and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of translational medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. SNRK (Sucrose Nonfermenting 1-Related Kinase) Promotes Angiogenesis In Vivo.Arteriosclerosis, thrombosis, and vascular biology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Xiaoyong TanDrug Discovery Research Center, Southwest Medical University, Luzhou, Sichuan, China.
Kai YanRenshou People's Hospital, Renshou, Sichuan, China.
Meiping RenDrug Discovery Research Center, Southwest Medical University, Luzhou, Sichuan, China.
Ni ChenDrug Discovery Research Center, Southwest Medical University, Luzhou, Sichuan, China.
Yongjie LiDrug Discovery Research Center, Southwest Medical University, Luzhou, Sichuan, China.
Xin DengDrug Discovery Research Center, Southwest Medical University, Luzhou, Sichuan, China.
Liqun WangDrug Discovery Research Center, Southwest Medical University, Luzhou, Sichuan, China.
Rong LiDrug Discovery Research Center, Southwest Medical University, Luzhou, Sichuan, China.
Mao LuoDrug Discovery Research Center, Southwest Medical University, Luzhou, Sichuan, China.
Yong LiuDrug Discovery Research Center, Southwest Medical University, Luzhou, Sichuan, China.
Yan LiuDrug Discovery Research Center, Southwest Medical University, Luzhou, Sichuan, China.
Jianbo WuDrug Discovery Research Center, Southwest Medical University, Luzhou, Sichuan, China. wuji@missouri.edu.
Southwest Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAngiopoietin-2 (Ang-2), a ligand of the Tie-2 receptor, plays an important role in maintaining endothelial cells and in destabilizing blood vessels. Collateral artery growth (arteriogenesis) is a key adaptive response to arterial occlusion. It is unknown whether the destabilization of blood vessels by Ang-2 can affect arteriogenesis and modulate mononuclear cell function. This study aimed to investigate the effects of Ang-2 on collateral artery growth.

methodsHindlimb ischaemia model was produced in C57BL/6 mice by femoral artery ligation. Blood flow perfusion was measured using a laser Doppler perfusion imager quantitative RT-PCR analysis was applied to identify the level of angiogenic factors.

resultsAfter the induction of hindlimb ischaemia, blood flow recovery was impaired in mice treated with recombinant Ang-2 protein; this was accompanied by a reduction of peri-collateral macrophage infiltration. In addition, quantitative RT-PCR analysis revealed that Ang-2 treatment decreased monocyte chemotactic protein-1 (MCP-1), platelet-derived growth factor-BB (PDGF-BB) mRNA levels in ischaemic adductor muscles. Ang-2 can lead to macrophage M1/M2 polarization shift inhibition in the ischaemic muscles. Furthermore, Ang-2 reduced the in vitro inflammatory response in macrophages and vascular cells involved in arteriogenesis.

conclusionsOur results demonstrate that Ang-2 is essential for efficient arteriogenesis, which controls macrophage infiltration.

Indexed as

Collateral CirculationAngiopoietin-2AnimalsArteriesCell MovementGene Expression RegulationHindlimbHumansInflammationIschemiaMacrophagesMaleMice, Inbred C57BLMuscle, Smooth, VascularMyocytes, Smooth MusclePerfusionAngiopoietin-2Recombinant ProteinsAngiopoietin-2ArteriogenesisIschaemiaMacrophage

Identifiers

PMID27784306
PMCPMC5080762
OpenAlexW2535739319

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.